Location History:
- Taby, SE (2006 - 2018)
- Täby, SE (2015 - 2018)
Company Filing History:
2 out of 3 
2 out of 329 
2 out of 3 Years Active: 2006-2018
Title: Claes Andersson: Innovator in Medical Research
Introduction
Claes Andersson is a notable inventor based in Täby, Sweden. He has made significant contributions to the field of medical research, particularly in the development of treatments for rare diseases. With a total of 6 patents to his name, Andersson's work has had a profound impact on the medical community.
Latest Patents
Among his latest patents is a process for the production and purification of recombinant lysosomal alpha-mannosidase. This invention relates to a method for purifying recombinant alpha-mannosidase, which is crucial for treating alpha-mannosidosis. The patent also covers the use of this composition as a medicament and outlines methods for alleviating the symptoms of alpha-mannosidosis. Another significant patent involves an animal model of Krabbe's disease, which serves as a tool for screening and validating potential treatments for globoid cell leukodystrophy.
Career Highlights
Throughout his career, Claes Andersson has worked with prominent companies in the pharmaceutical industry, including Shire Pharmaceuticals and Chiesi Farmaceutici. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Andersson has collaborated with esteemed colleagues such as Jens Fogh and Cecilia Weigelt. These partnerships have fostered a collaborative environment that enhances the research and development of new medical treatments.
Conclusion
Claes Andersson's contributions to medical research and his innovative patents highlight his dedication to improving healthcare. His work continues to inspire advancements in the treatment of rare diseases, making a lasting impact on the field.